Group 1 - The company N Beixin-U (688712) was listed today, opening with a rise of 187.16%, and closing with a gain of 183.33%, with a total trading volume of 28.16 million shares and a turnover of 1.409 billion yuan, resulting in a turnover rate of 75.88% [1][2] - The company specializes in the research, development, production, and sales of innovative medical devices for precise diagnosis and treatment of cardiovascular diseases, aiming to provide transformative solutions for cardiovascular disease diagnosis and treatment [1] - The core products include the intravascular ultrasound (IVUS) diagnostic system, which is the first domestically developed 60MHz high-definition IVUS product approved by the National Medical Products Administration, and the fractional flow reserve (FFR) measurement system, which is the first domestically approved product in the gold standard FFR field [1] Group 2 - The total number of shares issued by the company is 57 million, with an online issuance of 13.68 million shares at a price of 17.52 yuan per share, resulting in a final online subscription rate of 0.03264275% [2] - The initial fundraising amount is 999 million yuan, primarily directed towards the construction of an industrial base for interventional medical devices, research and development projects, working capital supplementation, and marketing network construction [2]
N北芯-U首日收盘涨183.33%